FDA issued a Warning Letter to Cispharma Inc. on 7/2/2013 as a result of this inspection.
FDA investigators audited the Cispharma - Cranbury, NJ, United States facility and issued inspectional observations (via FDA 483) on 23 Apr 2012.
Add To Cart
- Category: Human Drugs
- Inspection end: 23 Apr 2012
- Location: Cranbury, United States
- FEI: 3008276856